Glucose worsens hypoxic-ischemic brain injury in 0- to 3-day-old piglets. Piglets were randomly assigned to have blood glucose increased with glucose infusion (n = 12), or decreased with insulin (n = 13), or a sham group (n = 10). In the insulin and glucose groups at time 0, both carotid arteries were clamped, and blood was withdrawn to reduce the blood pressure one third. At time 15 min FiO2 was reduced to 6%. At time 30 min cerebrospinal fluid (CSF) was taken for glutamate, and the brains were frozen. The shams had CSF removed and brains frozen without hypoxia or ischemia. Brain ATP was 1.7 ± 0.09 μmol/g wet weight in the shams, 0.98 ± 0.09 in the glucose group (p < 0.01 vs. sham), and 0.52 ± 0.10 in the insulin group (p < 0.01 vs. glucose). Brain lactate levels were 4.3 ± 1.0 μmol/g wet weight in the shams, 18.3 ± 1.9 in the insulin group (p < 0.01 vs. sham), and 29.4 ± 2.6 in the glucose group (p < 0.01 vs. insulin). CSF glutamate was 9.3 ± 3.6 μM in the glucose group, 9.6 ± 3.5 in the insulin group, and 2.2 ± 0.9 in the shams (p < 0.05, glucose and insulin > sham). The Bmax for MK-801 binding was 2.3 ± 0.2 pmol/mg protein in the glucose group, 2.6 ± 0.1 in the insulin group (p < 0.05 vs. sham), and 2.0 ± 0.2 in the shams, and the Kd was the same in the three groups (p = nonsignificant). Brain Na+, K+-ATPase was the same in the three groups (p = nonsignificant). Providing additional glucose preserves ATP during hypoxic-ischemic brain injury in the piglet but does not change CSF glutamate or brain-801 binding and probably worsens outcome by elevating brain lactate levels above the threshold for cellular injury.

Keywords:
Hypoxia, Ischemia, N-Methyl-D-aspartate, Glutamate, Glycine, Insulin, Na+K+-ATPase
This content is only available via PDF.
© 1997 S. Karger AG, Basel
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.